Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread: 6.00 (0.042%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

AstraZeneca jab could help people with severe asthma come off steroids
27 Nov 2025

AstraZeneca jab could help people with severe asthma come off steroids

(Alliance News) - A monthly injection could help people with severe asthma come off daily steroid tablets entirely without any impact on symptoms, a t...

US Medicare price cuts manageable for most drugmakers, analysts say
26 Nov 2025

US Medicare price cuts manageable for most drugmakers, analysts say

Novo Nordisk, Teva shares rise, AbbVie's drops *

Polar Capital Global Healthcare has "overwhelming" shareholder support
26 Nov 2025

Polar Capital Global Healthcare has "overwhelming" shareholder support

(Alliance News) - Polar Capital Global Healthcare Trust PLC on Wednesday hailed "a very strong statement" in the result of its tender offer for shares...

AstraZeneca secures US approval for Imfinzi in gastric cancer
26 Nov 2025

AstraZeneca secures US approval for Imfinzi in gastric cancer

(Sharecast News) - Drugmaker AstraZeneca said on Wednesday that its Imfinzi asset has been approved in the US for use alongside standard FLOT chemothe...

Medicare announces discounts on 15 drugs, including Ozempic and Wegovy
26 Nov 2025

Medicare announces discounts on 15 drugs, including Ozempic and Wegovy

(Alliance News) - The US government on Tuesday announced cuts to the prices of 15 drugs through the Medicare health insurance system, including major ...

AstraZeneca's Imfinzi wins US approval for gastroesophageal cancer
25 Nov 2025

AstraZeneca's Imfinzi wins US approval for gastroesophageal cancer

(Alliance News) - AstraZeneca PLC on Tuesday said Imfinzi has been approved in the US as the first and only perioperative immunotherapy for patients w...

AstraZeneca to spend $2bn in US manufacturing push
24 Nov 2025

AstraZeneca to spend $2bn in US manufacturing push

(Sharecast News) - AstraZeneca is to invest $2bn ramping up manufacturing facilities in Maryland, America, the blue chip drugs giant said on Monday.

AstraZeneca unveils USD2 billion manufacturing investment in Maryland
21 Nov 2025

AstraZeneca unveils USD2 billion manufacturing investment in Maryland

(Alliance News) - AstraZeneca PLC on Friday announced plans to invest USD2 billion to expand its long-standing manufacturing footprint in Maryland.